FDA Approves Samsung Bioepis’ Humira Biosimilar - Myhealthyclick

FDA Approves Samsung Bioepis’ Humira Biosimilar  Myhealthyclick

On Tuesday, the U.S. Food and Drug Administration (FDA) approved Samsung Bioepis' biosimilar to Humira, a blockbuster drug for rheumatoid arthritis ...



Comments

Popular posts from this blog

Fibromyalgia — Latest Stories — Pain News Network

Chronic Lyme arthritis: A mystery solved?

Epstein-Barr virus and autoimmune diseases